ARCHIVES

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012

Duke recruits Judd Moul as chief of urology.

July 9, 2004

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991

NTP Release Third Report On Carcinogens

January 13, 1984

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

IOM Selects Advisors To Defense Department

February 5, 1993